AstraZeneca India plunges; delisting decision delayed

Tags: Companies
AstraZeneca Pharma India shares plunge after its board late on Wednesday deferred a proposal to delist the company from Indian exchanges.

The board deferred the proposal saying it would seek additional information from its promoter AstraZeneca Pharmaceuticals AB Sweden, which had sought the delisting.

AstraZeneca shares surged 47 percent in the four trading sessions till Tuesday on expectation that the delisting price would be at a substantial premium to the existing market price of the company.

AstraZeneca shares down 7.6 percent at 1,086 rupees as of 11.13 p.m.

EDITORIAL OF THE DAY

  • Not warnings, total prohibition of smoking is the only answer to restoring citizens’ health

    In a landmark judgment the Supreme Court on Wednesday said the tobacco industry must adhere to government rules requiring stringent health warnings on

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Urs Schoettli

Japan’s seismic shocks raise big questions

In the middle of April the region of Kumamoto on ...

Zehra Naqvi

The flame of hate

Pyre. The name itself evokes a sense of foreboding, casting ...

Bubbles Sabharwal

Whiners and complainers, please exit

We all know WC stands for a water closet, a ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture